학술논문
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
Document Type
Article
Author
Mehnert, J.M.; Groisberg, R.; Silk, A.W.; Mitchell, T.C.; Huang, A.C.; Schuchter, L.M.; Linette, G.P.; Karakousis, G.C.; Mitnick, S.; Giles, L.; Carberry, M.; Frey, N.; Amaravadi, R.K.; Aleman, T.S.; Kim, B.J.; Kossenkov, A.; Hernandez-Aya, L.F.; Ansstas, G.; Chandra, S.; Sosman, J.A.; Gimotty, P.A.; Mick, R.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 March 2022, 28(6):1098-1106)
Subject
Language
English
ISSN
15573265
10780432
10780432